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Epileptiform abnormalities contribute to progressive
deterioration of cerebral function. Considered: Ohtahara
Syndrome; Early myoclonic epileptic encephalopathy;
West Syndrome; Dravet Syndrome; Myoclonic status in
not progressive encephalopathies; CDKL5 encephalopaty.
Ohtahara syndrome (OS) early infantile encephalopa-
thy (EIEE). Most cases linked to cerebral malformations or
very occasionally to metabolic disorders. Main seizures:
tonic spasms, tonico- clonic, myoclonic and atonic and
partial spasms. Treatment Vigabatrin, Topamax, Zone-
gran, Steroids, ACTH and Ketogenic diet, vagal stimula-
tion and more invasive surgery. Mutations of the gene
STBX1 (Sintaxin binding protein) Mutations of SPTA
gene and GC1 have been reported. Prognosis is poor.
Early Myoclonic Encephalopathy (EME). Onset: neo-
natal period or first months of life. Seizures mainly erratic,
myoclonic or partial, tonic spasms. EEG burst suppression.
Etiology mostly unknown. Inborn errors of metabolism as
nonketotic hyperglycinemia, or propionic acidemia
reported . Prognosis poor. Therapy similar to that for OS.
West Syndrome (WS) aka as infantile spasms with
hypsarrhythmia, EEG abnormality with asynchronous very
high amplitude, irregular, continuous multifocal spike an
slow wave discharges. In 80% of cases a cause can be
found or suspected (symptomatic or criptogenethic)In
about 20% of patients no cause can be found (idiopathic).
1:3200 / 1:3500 newborns. Causes: infections, cerebral
malformations, hypoxic ischemic injuries, metabolic and
genetic disorders, tuberosclerosis. Corticotropin consid-
ered effective. This finding later confirmed. No definite
therapeutic scheme. High dose and long term treatment
associated with hypertension, cuschingoid features and
ipokalemia. Vigabatrin and Topiramate useful. Zonisa-
mide, Lamotrigine and Levetiracetam can be used. Prog-
nosis much better in idiopathic cases when treatment is
started within the first month from the appearance of the
symptoms.
Myoclonic status in nonprogressive encephalopa-
thies. Rare, onset in the first years of life. Partial motor
seizures, myoclonic absences or massive myoclonias some-
times with startles. Interictal EEG epileptiform discharges
and background slowing. Described in genetic conditions
like Angelman and 4p – syndromes. Prognosis poor.
Dravet syndrome (Severe myoclonic infantile epi-
lepsy or SMEI). 1/500 cases of infantile epilepsy. Febrile
convulsions in the first year. Subsequently myoclonic sei-
zure with fever. Photosensitivity. In 70% of cases muta-
tions of SCN1A gene. Difficult to treat. Topiramate,
Clobazam, Stiripentol.
CDKL5 Encephalopathy. Mutations in the human X
linked cyclin–dipendent kinase like 5 (CDKL5), infantile
spasms and Rett (RTT) like phenotype. Initially normal
EEG and severe hypotonia. Aquired microcephaly and
hand stereotypes. Identified with early infantile epileptic
encephalopathy 2. Prognosis severe.
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